Cargando…

A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier

The blood-brain barrier (BBB) is a sophisticated and very selective dynamic interface composed of endothelial cells expressing enzymes, transport systems, and receptors that regulate the passage of nutrients, ions, oxygen, and other essential molecules to the brain, regulating its homeostasis. Moreo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortés, Hernán, Alcalá-Alcalá, Sergio, Caballero-Florán, Isaac H., Bernal-Chávez, Sergio A., Ávalos-Fuentes, Arturo, González-Torres, Maykel, González-Del Carmen, Manuel, Figueroa-González, Gabriela, Reyes-Hernández, Octavio D., Floran, Benjamín, Del Prado-Audelo, María L., Leyva-Gómez, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559907/
https://www.ncbi.nlm.nih.gov/pubmed/32872576
http://dx.doi.org/10.3390/membranes10090212
Descripción
Sumario:The blood-brain barrier (BBB) is a sophisticated and very selective dynamic interface composed of endothelial cells expressing enzymes, transport systems, and receptors that regulate the passage of nutrients, ions, oxygen, and other essential molecules to the brain, regulating its homeostasis. Moreover, the BBB performs a vital function in protecting the brain from pathogens and other dangerous agents in the blood circulation. Despite its crucial role, this barrier represents a difficult obstacle for the treatment of brain diseases because many therapeutic agents cannot cross it. Thus, different strategies based on nanoparticles have been explored in recent years. Concerning this, chitosan-decorated nanoparticles have demonstrated enormous potential for drug delivery across the BBB and treatment of Alzheimer’s disease, Parkinson’s disease, gliomas, cerebral ischemia, and schizophrenia. Our main objective was to highlight the high potential of chitosan adsorption to improve the penetrability through the BBB of nanoformulations for diseases of CNS. Therefore, we describe the BBB structure and function, as well as the routes of chitosan for crossing it. Moreover, we define the methods of decoration of nanoparticles with chitosan and provide numerous examples of their potential utilization in a variety of brain diseases. Lastly, we discuss future directions, mentioning the need for extensive characterization of proposed nanoformulations and clinical trials for evaluation of their efficacy.